- The first-quarter operating profit of Hyundai Glovis exceeded the estimated figures. The actual operating profit was 384.77 billion won, compared to the estimated 378.79 billion won.
- Hyundai Glovis‘ net worth in the first quarter rose to 304.26 billion won, higher than the predicted 276 billion won.
- In terms of sales, Hyundai Glovis surpassed the expectations again with figures reaching 6.59 trillion won as against the estimated 6.52 trillion won.
- The company received 15 buy ratings, was held once, and sold once.
A look at Hyundai Glovis Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 4 | |
| Growth | 4 | |
| Resilience | 4 | |
| Momentum | 3 | |
| OVERALL SMART SCORE | 3.8 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Hyundai Glovis, a company providing domestic and international logistic services, appears to have a positive long-term outlook based on the Smartkarma Smart Scores. With strong scores across key factors such as value, dividend, growth, resilience, and momentum, the company seems well-positioned to thrive in the market. This bodes well for Hyundai Glovis‘ overall performance and stability in the foreseeable future.
Notably, Hyundai Glovis scored consistently high across various aspects, indicating a robust foundation and potential for growth. With solid marks in value, dividend, growth, resilience, and commendable momentum, the company showcases promising fundamentals in its industry. Investors may find Hyundai Glovis an attractive prospect given its favorable Smart Scores and the company’s diverse range of services including domestic transportation, storage, packaging, vehicle logistics, logistic consulting, and operations in the automobile auction market for used vehicles.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
